About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Oncology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Clinical Trials in Myeloma in 2018
By
Krina Patel
4 Videos
June 22, 2018
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
Scripps MD Anderson Cancer Center
Scripps MD Anderson Cancer Center's Clinical Hematology & Oncology 2021
Sat, Feb 20, 2021
The Royal Marsden School
Demystifying the Science Behind Targeted Treatments for Haematological C...
Tue, Feb 2, 2021
Total Health Conferencing
Virtual West Oncology Conference
Fri, Feb 26, 2021
14:15
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
MRD in Multiple Myeloma Isn't Ready for Prime Time: More Patients Can Ac...
Feat.
T. Martin
14:16
2nd SOHO Italian Conference
2020 SOHO Update on MM: What Is the Role of Transplant and MRD? How Do T...
Feat.
K. Anderson
25:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases
MM - Overview of Trials Presented at ASH 2018
Feat.
A. Abdallah
26:18
Morie Gertz
Treatment of Relapsed Myeloma: Overview of Approved Drugs, mSMART Classi...
13:23
Parameswaran Hari
CAR T and NK Cell Therapy in Myeloma
08:15
2018 Pan Pacific Lymphoma Conference
Evolution of Myeloma Induction Regimens
Feat.
S. Holstein
22:47
UChicago CAR T-Cell Symposium 2019
Patient Selection for CAR T-Cell Therapy: Therapeutic Benefits, Discussi...
Feat.
M. Leukam
23:48
UChicago CAR T-Cell Symposium 2019
2019 Update on CAR-T in Multiple Myeloma - Can We Improve Upon These Res...
Feat.
J. Jasielec
09:00
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Treatment Options in R/R Multiple Myeloma: Tips for Selecting Among the ...
Feat.
J. Berdeja
12:16
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Discrepancy Between Real World vs. Clinical Trial Data in Relapsed/Refra...
Feat.
M. Dimopoulos
12:03
Andrew Cowan
BCMA CAR-T + Gamma Secretase Inhibitor Appear to Be Well Tolerated in R/...
06:21
Cleveland Clinic's 20th Annual ASH Review
2019 ASH Review on Relapsed/Refractory: CAR T Cells - A New Frontier in ...
Feat.
F. Anwer
09:50
Nina Shah
Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maint...
19:41
Peter Voorhees
Approach to the Patient with Refractory & Multiple Relapsed Multiple Mye...
06:12
Indy Hematology Review
Targeting Mutations in Myeloma with Venetoclax and Development of the Fi...
Feat.
K. Anderson
27:06
UChicago CAR T-Cell Symposium 2019
Why Does CAR T-Cell Therapy Fail? An Update on Mechanisms of Resistance/...
Feat.
J. Kline
10:30
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Next Questions in Myeloma: Biology, Smoldering Myeloma, High-risk, MRD, ...
Feat.
S. Jagannath
07:57
Penn Medicine 2020 Updates in Oncology
ASCO Update on Myeloma: How Promising Are BCMA CAR-T & BCMA x CD3 Bispec...
Feat.
D. Vogl
15:47
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...
Feat.
S. Lonial
15:11
Ajay Nooka
Early Relapse: Choosing Among Different Second Line Regimens in Myeloma